VOYA Investment Management
PLX icon

VOYA Investment Management’s Protalix BioTherapeutics PLX Stock Holding History

VOYA Investment Management’s Portfolio PLX Stock Details PLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$25K Sell
10,717
-777
-7% -$1.65K ﹤0.01% 2481
2026
Q1 		$24.9K Buy
+11,494
New +$28.5K ﹤0.01% 2326
2024
Q2 		– Sell
-27,023
Closed -$34K – 2889
2024
Q1 		$34K Sell
27,023
-2,242
-8% -$3.35K ﹤0.01% 2757
2023
Q4 		$52.1K Hold
29,265
– – ﹤0.01% 2846
2023
Q3 		$48.6K Buy
29,265
+5,386
+23% +$9.67K ﹤0.01% 2856
2023
Q2 		$47.8K Buy
+23,879
New +$56.9K ﹤0.01% 2904

Other funds holding PLX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SWP
Stratos Wealth Partners Beachwood, Ohio $9.93B AUM 28.91% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

VOYA Investment Management's PLX Position: Q2 2026 in Review

VOYA Investment Management reduced its Protalix BioTherapeutics (PLX) stake by 6.8% in Q2 2026, selling an estimated $1.65K and leaving 10,717 shares worth $25K. The position accounts for ﹤0.01% of the portfolio, ranked #2481.

VOYA Investment Management first reported a position in PLX in Q2 2023 and has held it in 6 quarters since. The position peaked at $52.1K in Q4 2023. 102 funds tracked by Wall St. Rank hold PLX as of Q2 2026.

  • VOYA Investment Management held 10,717 shares of Protalix BioTherapeutics worth $25K as of Q2 2026.
  • VOYA Investment Management sold 777 Protalix BioTherapeutics shares in Q2 2026, an estimated $1.65K.
  • Protalix BioTherapeutics made up ﹤0.01% of VOYA Investment Management's portfolio in Q2 2026, its #2481 holding.
  • VOYA Investment Management first reported a position in Protalix BioTherapeutics in Q2 2023 and has held it in 6 quarters since.
  • VOYA Investment Management's Protalix BioTherapeutics position peaked at $52.1K in Q4 2023.
  • 102 funds tracked by Wall St. Rank held Protalix BioTherapeutics as of Q2 2026.

Based on VOYA Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.